Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers
Phase 1
Terminated
- Conditions
- SafetyPharmacokinetics
- Interventions
- Drug: single E4 28.3 mgDrug: single E4 94.4 mgDrug: multiple E4 94.4 mgDrug: Placebo
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- NEURALIS s.a.
- Target Recruit Count
- 8
- Registration Number
- NCT05460065
- Locations
- 🇧🇬
MC Comac Medical Ltd, Sofia, Bulgaria
Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- NEURALIS s.a.
- Target Recruit Count
- 162
- Registration Number
- NCT04801836
- Locations
- 🇧🇪
ERASME Hospital, Brussels, Belgium
🇧🇪CHR Citadelle, Liège, Belgium
🇭🇺Koranyi National Institute of Pulmonology, Budapest, Hungary
News
No news found